| Update of the stroke therapy academic industry roundtable preclinical recommendations M Fisher, G Feuerstein, DW Howells, PD Hurn, TA Kent, SI Savitz, EH Lo Stroke 40 (6), 2244-2250, 2009 | 1506 | 2009 |
| Concise review: MSC adhesion cascade—insights into homing and transendothelial migration F Nitzsche, C Müller, B Lukomska, J Jolkkonen, A Deten, J Boltze Stem cells 35 (6), 1446-1460, 2017 | 396 | 2017 |
| Stem cell therapy as an emerging paradigm for stroke (STEPS) II SI Savitz, M Chopp, R Deans, ST Carmichael, D Phinney, L Wechsler Stroke 42 (3), 825-829, 2011 | 317 | 2011 |
| Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial … GW Albers, LB Goldstein, DC Hess, LR Wechsler, KL Furie, PB Gorelick, ... Stroke 42 (9), 2645-2650, 2011 | 239 | 2011 |
| Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles NA Terpolilli, SW Kim, SC Thal, H Kataoka, V Zeisig, B Nitzsche, ... Circulation research 110 (5), 727-738, 2012 | 232 | 2012 |
| The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity L Cui, E Kerkelä, A Bakreen, F Nitzsche, A Andrzejewska, A Nowakowski, ... Stem Cell Research & Therapy 6, 1-9, 2015 | 202 | 2015 |
| Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials JL Saver, GW Albers, B Dunn, KC Johnston, M Fisher Stroke 40 (7), 2594-2600, 2009 | 197 | 2009 |
| Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease D Kaiser, G Weise, K Möller, J Scheibe, C Pösel, S Baasch, M Gawlitza, ... Acta neuropathologica communications 2, 1-15, 2014 | 190 | 2014 |
| Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS) Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating … STEPS Participants Stroke 40 (2), 510-515, 2009 | 170 | 2009 |
| Stroke treatment academic industry roundtable X: brain cytoprotection therapies in the reperfusion era SI Savitz, JC Baron, M Fisher, STAIR X Consortium Stroke 50 (4), 1026-1031, 2019 | 168 | 2019 |
| The dark side of the force–constraints and complications of cell therapies for stroke J Boltze, A Arnold, P Walczak, J Jolkkonen, L Cui, DC Wagner Frontiers in Neurology 6, 155, 2015 | 167 | 2015 |
| Density gradient centrifugation compromises bone marrow mononuclear cell yield C Pösel, K Möller, W Fröhlich, I Schulz, J Boltze, DC Wagner PloS one 7 (12), e50293, 2012 | 166 | 2012 |
| Stem cells as an emerging paradigm in stroke 3 SI Savitz, SC Cramer, L Wechsler, J Aronowski, J Boltze, C Borlongan, ... Stroke, 2014 | 165 | 2014 |
| Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches R Diehl, F Ferrara, C Müller, AY Dreyer, DD McLeod, S Fricke, J Boltze Cellular & molecular immunology 14 (2), 146-179, 2017 | 160 | 2017 |
| Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats A Kranz, DC Wagner, M Kamprad, M Scholz, UR Schmidt, F Nitzsche, ... Brain research 1315, 128-136, 2010 | 145 | 2010 |
| Current and emerging avenues for Alzheimer's disease drug targets R Loera‐Valencia, A Cedazo‐Minguez, PA Kenigsberg, G Page, ... Journal of internal medicine 286 (4), 398-437, 2019 | 144 | 2019 |
| A concerted appeal for international cooperation in preclinical stroke research U Dirnagl, A Hakim, M Macleod, M Fisher, D Howells, SM Alan, ... Stroke 44 (6), 1754-1760, 2013 | 120 | 2013 |
| Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia J Boltze, A Förschler, B Nitzsche, D Waldmin, A Hoffmann, CM Boltze, ... Journal of Cerebral Blood Flow & Metabolism 28 (12), 1951-1964, 2008 | 117 | 2008 |
| Top priorities for cerebroprotective studies—a paradigm shift: report from STAIR XI P Lyden, A Buchan, J Boltze, M Fisher Stroke 52 (9), 3063-3071, 2021 | 109 | 2021 |
| Stem cell–based tissue replacement after stroke: factual necessity or notorious fiction? M Janowski, DC Wagner, J Boltze Stroke 46 (8), 2354-2363, 2015 | 108 | 2015 |
Daniel-Christoph WagnerInstitute of Pathology, University Medical Center Mainz, GermanyVerificeret mail på unimedizin-mainz.de
